Virginia resident Ken Robson, 64, had been visiting his son in the San Diego area in mid-June. “I had been noticing that I had been feeling weak and lightheaded,” he said. He also noticed severe drops ...

Pathway Genomics is currently marketing an unapproved screening tool, which the US Food and Drug Administration (FDA) believes to be a medical device, for the early detection of up to 10 different ...

SAN DIEGO--(BUSINESS WIRE)--Pathway Genomics Corporation, a San Diego-based CLIA and CAP accredited clinical laboratory that offers genetic testing services globally, announced that world-renowned ...

Pathway Genomics said that it has launched BRCATrue, a next- generation sequencing and deletion/duplication analysis that can detect mutations in BRCA1 and BRCA2, the genes linked to breast, ovarian ...

SAN DIEGO--(BUSINESS WIRE)--Pathway Genomics, a genetic testing laboratory on the forefront of bringing physicians a broad genetic testing portfolio covering a wide range of diseases, announces the ...

Pathway Genomics Corp., a San Diego-based CAP-accredited clinical laboratory that offers genetic testing services worldwide, announced it has appointed Robert C. Verfurth as vice president of sales.

Pathway Genomics Corporation, a global precision medicine company with mobile health solutions, today announced it has successfully raised over $40 million in a Series E financing. This brings the ...

Under the settlement agreement, Myriad and its co-patent holders—including the University of Utah, the University of Pennsylvania, and Endorecherche, Inc., of Québec—will dismiss their claims, and ...